Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Sarobe

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Vaccine|November 27, 2002
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virusLaura Arribillaga, Ascensión López Díaz de Cerio, Pablo Sarobe, et al.
Frontiers in Immunology|January 11, 2020
Genetic Modification of CD8<sup>+</sup> T Cells to Express EGFR: Potential Application for Adoptive T Cell TherapiesTeresa Lozano, Silvia Chocarro, Celia Martin, et al.
Cytokine|September 7, 2007
Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide libraryJavier Dotor, Ana B López-Vázquez, Juan J Lasarte, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 20, 2014
Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulationNerea Fernandez-Ros, Mercedes Iñarrairaegui, Jose A Paramo, et al.
Frontiers in Immunology|November 21, 2022
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancerBelén Aparicio, David Repáraz, Marta Ruiz, et al.
Frontiers in Immunology|October 27, 2022
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccinationDavid Repáraz, Marta Ruiz, Leyre Silva, et al.
Cancer Research|September 5, 2008
Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunityEduardo Huarte, Juan R Cubillos-Ruiz, Yolanda C Nesbeth, et al.
Transplant Immunology|July 31, 2015
Immune monitoring of immunosuppression withdrawal of liver transplant recipientsRocío García de la Garza, Pablo Sarobe, Juana Merino, et al.
Cancer Letters|January 1, 2022
TCR-induced FOXP3 expression by CD8<sup>+</sup> T cells impairs their anti-tumor activityTeresa Lozano, Enrique Conde, Celia Martín-Otal, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infectionAintzane Zabaleta, Delia D'Avola, Itziar Echeverria, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Vaccine|November 27, 2002
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virusLaura Arribillaga, Ascensión López Díaz de Cerio, Pablo Sarobe, et al.
Frontiers in Immunology|January 11, 2020
Genetic Modification of CD8<sup>+</sup> T Cells to Express EGFR: Potential Application for Adoptive T Cell TherapiesTeresa Lozano, Silvia Chocarro, Celia Martin, et al.
Cytokine|September 7, 2007
Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide libraryJavier Dotor, Ana B López-Vázquez, Juan J Lasarte, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 20, 2014
Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulationNerea Fernandez-Ros, Mercedes Iñarrairaegui, Jose A Paramo, et al.
Frontiers in Immunology|November 21, 2022
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancerBelén Aparicio, David Repáraz, Marta Ruiz, et al.
Frontiers in Immunology|October 27, 2022
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccinationDavid Repáraz, Marta Ruiz, Leyre Silva, et al.
Cancer Research|September 5, 2008
Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunityEduardo Huarte, Juan R Cubillos-Ruiz, Yolanda C Nesbeth, et al.
Transplant Immunology|July 31, 2015
Immune monitoring of immunosuppression withdrawal of liver transplant recipientsRocío García de la Garza, Pablo Sarobe, Juana Merino, et al.
Cancer Letters|January 1, 2022
TCR-induced FOXP3 expression by CD8<sup>+</sup> T cells impairs their anti-tumor activityTeresa Lozano, Enrique Conde, Celia Martín-Otal, et al.
Molecular Therapy. Methods & Clinical Development|June 2, 2015
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infectionAintzane Zabaleta, Delia D'Avola, Itziar Echeverria, et al.
Pageof 9